Welcome to our dedicated page for JANUS LIVING news (Ticker: JAN), a resource for investors and traders seeking the latest updates and insights on JANUS LIVING stock.
The news page for JanOne Inc. (historically Nasdaq: JAN) provides an archive of company announcements and press releases that document its transition into ALT5 Sigma Corporation and the evolution of its business focus. These news items explain how the organization moved from being described primarily as a biopharmaceutical company focused on non-addicting pain treatments to a multidisciplinary entity combining healthcare initiatives with a growing fintech platform centered on blockchain-powered digital asset services.
Readers will find coverage of the company’s confirmation of its name change to ALT5 Sigma Corporation and ticker change to ALTS, reflecting a strategic realignment to focus on its recently acquired ALT5 Sigma fintech business as a core engine for revenue growth. News articles describe the acquisition and integration of ALT5 Sigma Inc., the company’s addition to the Russell Microcap Index, and subsequent developments such as the launch of the ALT5 Settlement Platform, the introduction of a prepaid Visa card integration, and reported transaction volumes processed by ALT5 subsidiaries.
The archive also includes updates on leadership appointments related to the fintech business, such as the naming of a Chief Revenue Officer and President for ALT5 Sigma, as well as communications about the company’s ongoing biotech activities aimed at addressing the opioid crisis. Earlier releases highlight JanOne’s efforts to develop non-addicting pain treatments and its dedication to funding innovation, technology, and education in this area.
By reviewing the JAN news feed, investors and researchers can trace key milestones, including the acquisition of ALT5 Sigma, strategic realignment decisions, and subsequent product and platform launches in digital payments and digital asset trading. Because the active Nasdaq ticker has changed from JAN to ALTS, this page serves as a historical record of announcements made under the JAN symbol, complementing more recent disclosures filed under the ALT5 Sigma Corporation identity.
JanOne (Nasdaq: JAN) has announced its inclusion in the Russell Microcap® Index, effective June 3, 2024. The Russell Microcap® Index, launched on June 1, 2005, measures the performance of the microcap segment of the US equity market and includes 1,000 securities.
This milestone follows JanOne's recent acquisition of ALT 5 Sigma and is expected to enhance the company's visibility among investment managers and institutional investors.
CEO Tony Isaac highlighted the strategic importance of this inclusion for the company's development and future investment opportunities.
JanOne (Nasdaq: JAN) announced on May 16, 2024, the successful acquisition of blockchain fintech ALT 5 Sigma and its subsidiaries. ALT 5, established in 2018, offers blockchain technologies through platforms 'ALT 5 Pay' and 'ALT 5 Prime.' The acquisition comprises 1,799,100 shares of JanOne's common stock, constituting roughly 19.9% of its total outstanding shares, and 34,207 shares of Series B preferred stock. ALT 5's transactional volume reached $1.1 billion last year and $450 million in Q1 of this year. Both companies aim to leverage this acquisition for future growth and diversification.
JanOne Inc. (Nasdaq: JAN) has agreed to acquire ALT 5 Sigma Inc., a fintech provider specializing in blockchain technologies. ALT 5's transactional volume exceeded $1.1 billion in 2023 and $450 million in Q1 2024. The acquisition aims to leverage ALT 5's innovative solutions in the payment processing market. ALT 5 Pay and ALT 5 Prime are the two platforms offered by ALT 5, focusing on crypto-currency payment gateways and electronic OTC trading. The deal is expected to close the week of May 13th, 2024, subject to regulatory approval.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.